Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth.
The global Methyltestosterone market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Methyltestosterone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Methyltestosterone market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Methyltestosterone in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Methyltestosterone manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Impax Laboratories
Bausch Health
HARBIN PHARMACEUTICAL GROUP
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Capsules
Tablet
Segment by Application
Low testosterone levels in men
Delayed puberty in boys
Females
Summary:
Get latest Market Research Reports on Methyltestosterone. Industry analysis & Market Report on Methyltestosterone is a syndicated market report, published as Global Methyltestosterone Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Methyltestosterone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.